Gisele Youth, DPM
Podiatrist · Atlanta, GANPI 1710447537
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,509 of the $4,148 with a category attached, or 60.5%. 13 manufacturers reported payments, led by Stryker at 45.7% of the total. Reporting peaked in 2023 at $2,952 and has fallen 65.9% since, to $1,007 in 2024.
Across 48 payments — averaging $86.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medical Device Business Services, Inc.$790
- Smith+Nephew$479
- United Orthopedics LLC$322
- Arthrex$206
- Paragon 28, Inc.$158
- plus $298 from 7 others
What the payments were for
- Travel & lodging$2,50960%
- Food & beverage$1,63940%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 19 | $1,894 |
| Medical Device Business Services, Inc. | 6 | $790 |
| Smith+Nephew | 5 | $479 |
| United Orthopedics LLC | 3 | $322 |
| Arthrex | 4 | $206 |
| Paragon 28, Inc. | 2 | $158 |
| Ossio Inc | 1 | $128 |
| Johnson & Johnson | 2 | $45 |
| Integra Lifesciences Corporation | 1 | $30 |
| Bioventus LLC | 2 | $27 |
| Paratek Pharmaceuticals, Inc. | 1 | $25 |
| Kerecis Limited | 1 | $24 |
| Orthofix Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,148 in reported general payments places this provider in the 70th percentile of 177 podiatrist providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 64 | $1,431 |
| Ciclopirox | 25 | $421 |
| Terbinafine Hcl | 23 | $352 |
| Pregabalin | 37 | $259 |
| Mupirocin | 24 | $161 |
| Gabapentin | 20 | $75 |
| Meloxicam | 33 | $51 |
| Diclofenac Sodium | 13 | $43 |
| Cephalexin | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Atlanta
- Mohammad SharifAtlanta$79K
- Craig CamastaAtlanta$49K
- Margo JimenezAtlanta$19K
- Christopher BergenAtlanta$8K
- Guang YangAtlanta$8K
- Apeksha ReddyAtlanta$7K
- Brent Blanck-SingerAtlanta$6K
- Dane UlettAtlanta$5K
- Allen RaphaelSmyrna$324K
- Ira KrausFort Oglethorpe$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.